210.45 USD
↘ 8.39 (3.83%)AT CLOSE (11:59 AM EDT)
Ascendis Pharma A/S Ordinary Share
ASNDNASDAQ • USD
210.98
↗ 0.53 (0.25%)
POST MARKET (AS OF 06:44 PM EDT)
Post Market
AS OF 06:44 PM EDT
210.98
↗ 0.53 (0.25%)
Market: CLOSED
Open?$220.51
High?$222.55
Low?$209.56
Prev. Close?$218.84
Volume?592.7K
Avg. Volume?N/A
VWAP?$213.61
Bid / Ask
Bid?$84.57 × 200
Ask?$245.00 × 100
Spread?$160.43
Midpoint?$164.79
Valuation & Ratios
Market Cap?13.0B
Shares Out?N/A
Float?46.5M
Float %?75.1%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
Ascendis Pharma A/S Ordinary Share (ASND) is currently trading at $210.45. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 1/9 and a bullish Golden Cross on the moving averages.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?100
Momentum?50
Short Sent.?85
Piotroski F-Score?1/9Weak
Altman Z-Score?255.99Safe
Confidence?58%Low
Short InterestLow
Short % of Float?3.70%Low
Short Interest?1.7M
Days to Cover?2.8
Free Float46.5M
Avg Daily Volume623.4K
Settlement Date2026-05-15